Related Experiment Video

Updated: May 25, 2026

Static Strength Training Method for Type 2 Diabetic Mice
03:17

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic

Krzysztof C Lewandowski1, Ewa Banach, Małgorzata Bieńkiewicz

  • 1Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.

Archives of Medical Science : AMS
|February 1, 2012
PubMed
Abstract

Insights

Matrix metalloproteinases (MMPs) were lower in type 2 diabetes patients. MMP-9 levels correlated with HbA1c and changed during glucose challenges, indicating complex regulation in diabetes.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Nephrology

Background:

  • The role of matrix metalloproteinases (MMPs) in type 2 diabetes mellitus (DM) is complex, with conflicting observations in vasculature and kidneys.
  • Understanding MMPs' role is crucial for addressing diabetic nephropathy.

Purpose of the Study:

  • To investigate serum concentrations of MMP-2 and MMP-9 in individuals with type 2 DM compared to healthy controls.
  • To explore the relationship between MMP levels, glycemic control (HbA1c), and responses during an oral glucose tolerance test (OGTT).

Main Methods:

  • Serum MMP-2 and MMP-9 levels were measured in 22 type 2 DM patients and 32 controls.
  • MMP levels were re-assessed in a subset of diabetic patients post-hospital discharge and after 3 months.
  • MMP levels were also measured in controls during an OGTT.

Main Results:

  • Subjects with type 2 DM exhibited significantly lower serum concentrations of MMP-2 and MMP-9 compared to controls.
  • MMP-9 levels decreased during the OGTT in controls.
  • A positive correlation was observed between MMP-9 concentrations and HbA1c in diabetic subjects.
  • Diabetic patients showed a significant reduction in HbA1c after 3 months post-discharge, with a corresponding decrease in MMP-9 levels.

Conclusions:

  • Serum MMP-2 and MMP-9 concentrations are lower in individuals with type 2 DM.
  • MMP regulation in diabetes is intricate, influenced by both acute hyperglycemia during OGTT and chronic hyperglycemia reflected by HbA1c.
Keywords:
matrix metalloproteinasesoral glucose tolerance testtype 2 diabetes

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...